← Open Payments lookup

DAISY VO: Open Payments

NPI 1811331226 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,165 in 114 payments from 18 companies in 2025. Trend: 2023 $3,207 · 2024 $3,459 · 2025 $4,165

Food & beverage: $4,165
CompanyPaymentsAmount
ABBVIE INC.30$1,946
Gilead Sciences, Inc.25$687
Janssen Biotech, Inc.16$346
Novo Nordisk Inc4$166
Madrigal Pharmaceuticals1$142
Aimmune Therapeutics, Inc.2$140
Intra-Sana Laboratories7$136
Ipsen Biopharmaceuticals, Inc5$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$99
Regeneron Healthcare Solutions, Inc.3$67

Products named: SKYRIZI, RINVOQ, MAVYRET, TREMFYA, CREON, Wegovy, REZDIFFRA, ZENPEP.

Industry payments across NV — which companies pay providers there.